• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, September 2, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Immunology

Cellular protein a target for Zika control

Bioengineer by Bioengineer
January 16, 2019
in Immunology
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: Rasgon Lab, Penn State


A cellular protein that interacts with invading viruses appears to help enable the infection process of the Zika virus, according to an international team of researchers who suggest this protein could be a key target in developing new therapies to prevent or treat Zika virus infection.

Scientists first isolated Zika, a member of the Flaviviridae family of viruses — which also includes yellow fever, dengue and West Nile viruses — in 1947 and, until recently, it typically caused only mild symptoms in humans. However, health officials first recorded larger outbreaks of the mosquito-borne virus in 2007, culminating in a large epidemic in the Western Hemisphere in 2015-2016. For the first time, Zika infection also was associated with severe symptoms, including microcephaly in infants infected in the womb, and Guillain-Barre syndrome in adults.

These acute symptoms and the rapid spread of the virus prompted the World Health Organization to declare Zika a public health emergency of international concern and stimulated interest among scientists in the factors governing Zika infection, about which little is known.

In general, flavivirus infection in mammalian cells is mediated by an array of cell surface molecules and attachment cofactors, explained Sujit Pujhari, assistant research professor of entomology, College of Agricultural Sciences, Penn State. Previous work showed that heat shock protein 70 (Hsp70) is one such host molecule for several viruses, including dengue virus, Japanese encephalitis virus and rotavirus.

“In these instances, Hsp70 may act directly as a receptor or indirectly to help attach viruses on the cell surface, where they can interact with specific receptors,” Pujhari said. “Hsp70 also plays a role in controlling viral replication in several virus types, including influenza A and rabies. We hypothesized that Hsp70 might have similar functions in relation to Zika.”

The researchers, who published their findings in Emerging Microbes & Infections, tested this hypothesis by infecting human liver, human nerve and monkey kidney cells with Zika virus. When they used an Hsp70 antibody or a recombinant Hsp70 as a competitor to block the interaction between the protein and the virus, the amount of infectious virus in the cells was reduced, indicating that Hsp70 is involved with Zika virus’s ability to enter cells.

Researchers also found that Hsp70 influences replication of the virus. Their results showed that Zika virus infection induces the expression of Hsp70, and when they treated cells with an Hsp70 inhibitor to reduce production of the protein, it also reduced the production of infectious Zika virus particles. Similarly, when they induced overexpression of Hsp70, production of infectious viral particles was significantly elevated.

In addition, the team found that Zika-infected cells treated with the Hsp70 inhibitor contained increased levels of virus particles compared to the amount of observed extracellular virus. This accumulation of intracellular virus particles indicated that Hsp70 plays a role in the release of mature virus particles from cells.

“These findings show that Hsp70 is an integral host molecule for Zika virus infection of host cells, effecting multiple stages of the infection cycle — virus attachment to cells, viral replication inside cells and virus exit from infected cells,” said Jason Rasgon, professor of entomology and disease epidemiology, Penn State.

“Because there currently is no effective treatment or vaccine for Zika infection, it’s extremely important to develop therapies to reduce infection and severe clinical outcomes, particularly for pregnant women and developing fetuses,” he said. “The multiple critical roles of Hsp70 in the infectious life cycle of Zika virus validate Hsp70 as a potential target for future anti-Zika therapies.”

###

The research team also included Marco Brustolin and Vanessa Macias, postdoctoral scholars in entomology; Ruth Nissly, research technician and Suresh Kuchipudi, clinical associate professor, both in veterinary and biomedical sciences, Penn State. Also on the project was Masashi Nomura, associate professor, faculty of horticulture, Chiba University, Chiba, Japan.
The Penn State Huck Institutes of the Life Sciences and the National Institutes of Health, National Institute of Allergy and Infectious Diseases supported this study.

Media Contact
A’ndrea Elyse Messer
[email protected]
814-865-9481

Tags: BiologyInfectious/Emerging DiseasesVirology
Share12Tweet8Share2ShareShareShare2

Related Posts

IMAGE

UMass Amherst grad student awarded fellowship for food allergy research

July 23, 2021
IMAGE

Less-sensitive COVID-19 tests may still achieve optimal results if enough people tested

July 22, 2021

Public trust in CDC, FDA, and Fauci holds steady, survey shows

July 20, 2021

USC study shows male-female differences in immune cell function

July 19, 2021
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    154 shares
    Share 62 Tweet 39
  • Molecules in Focus: Capturing the Timeless Dance of Particles

    143 shares
    Share 57 Tweet 36
  • Needlestick Injury Rates in Nurses and Students in Pakistan

    123 shares
    Share 49 Tweet 31
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    117 shares
    Share 47 Tweet 29

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Nurse Activity Levels Linked to Work Demographics

Global Trends and Disparities in Urinary Tumors (1990-2046)

Fluorine “Forever Chemical” in Medicines Does Not Increase Drug Reaction Risks

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.